Verrica Pharmaceuticals Inc. (VRCA) SEC Filings — 2025
20 SEC filings for Verrica Pharmaceuticals Inc. (VRCA) in 2025.
Filings
- Verrica Pharmaceuticals Reports Director and Officer Changes — 8-K · Dec 30, 2025
- Verrica Pharmaceuticals Inc. 8-K Filing — 8-K · Nov 24, 2025
- Verrica Pharmaceuticals Files 8-K on Financials — 8-K · Nov 14, 2025
- Verrica Slashes Losses 84% on Revenue Surge, But Going Concern Looms — 10-Q · Nov 14, 2025
- Verrica Pharmaceuticals Files 8-K — 8-K · Aug 12, 2025
- Verrica's YCANTH Drives Revenue Growth, Narrows Q2 Loss — 10-Q · Aug 12, 2025
- Verrica Pharmaceuticals Faces Delisting Notice — 8-K · Jul 30, 2025
- Verrica Pharma Files 8-K on Security Holder Rights — 8-K · Jul 23, 2025
- Verrica Pharmaceuticals Files 8-K — 8-K · Jul 1, 2025
- Verrica Pharmaceuticals Enters Material Definitive Agreement — 8-K · Jun 12, 2025
- Verrica Pharmaceuticals Files 8-K on Shareholder Votes — 8-K · Jun 5, 2025
- Verrica Pharmaceuticals Files 8-K on Financials — 8-K · May 13, 2025
- Verrica Pharma Files Q1 2025 10-Q, Details Torii Deal & Financing — 10-Q · May 13, 2025
- Verrica Pharma Announces Board & Executive Changes — 8-K · Apr 25, 2025
- Verrica Pharma Details Executive Compensation and Equity Awards — DEF 14A · Apr 22, 2025
- Verrica Pharma Reports Director Changes & Compensation Updates — 8-K · Apr 2, 2025
- Verrica Pharmaceuticals Files 8-K on Financials — 8-K · Mar 11, 2025
- Verrica Pharmaceuticals Files 2024 10-K — 10-K · Mar 11, 2025
- Verrica Pharmaceuticals Enters Material Definitive Agreement — 8-K · Feb 21, 2025
- Verrica Pharmaceuticals Faces Nasdaq Delisting Notice — 8-K · Jan 30, 2025